Contrive Datum Insights has published "Medical Aesthetics Market Size, Share & Industry Analysis, By Type (Energy-based Devices, Non-energy-based Devices, Implants, Others), Application (Skin Resurfacing & Tightening, Body Contouring and Cellulite Reduction, Hair and Tattoo Removal, Breast Augmentation, Others), End-user (Hospitals, Specialty Clinics, Others), Procedure type (Invasive, Minimally Invasive, Non-invasive), Gender (Female, Male), and Regional Forecast, 2026-2034". The study sizes the global medical aesthetics market at USD 23.6 billion in 2025 and projects growth from USD 26.2 billion in 2026 to USD 56 billion by 2034, a compound annual growth rate of 9.96% across the forecast period.
Medical aesthetics covers the devices, injectable products and surgical or minimally invasive procedures used to alter or restore skin, body contour and facial appearance for cosmetic rather than reconstructive purposes. The category spans energy-based equipment such as laser, radiofrequency and ultrasound systems, injectable products including botulinum toxin and dermal fillers, and implant-based procedures such as breast and dental implants. Buyers range from hospitals and specialty dermatology or plastic surgery clinics to medical spas, with individual consumers as the end patient paying out of pocket in most cases.
Rising demand for minimally invasive and non-invasive procedures
Rising demand for minimally invasive and non-invasive procedures is the largest single contributor to the market's growth over the forecast period, and the study rates its impact high. Against a market growing at 9.96% a year, the type lines exposed to it move fastest: Energy-based Devices compounds at 11.05%, taking its share of revenue from 32% to 35% and its value from USD 7.55 billion to USD 19.6 billion.
A more favourable outcome is possible. If assumes faster adoption of minimally invasive procedures and quicker expansion of clinic networks across Asia Pacific, sustaining higher volume growth without a matching rise in average procedure pricing, 2034 revenue reaches USD 63.84 billion instead of the USD 56 billion the base case carries.
On the downside, assumes tighter regulatory review of energy-based devices and softer discretionary consumer spending, pulling average annual growth below the base case, particularly in price-sensitive markets in Latin America and the Middle East, which would hold 2034 revenue to USD 48.16 billion. Implants, which carries 25% of 2025 revenue, already grows at only 7.82% against the market's 9.96%, so the largest part of the base is also its slowest.
The Competitive Split Runs by Type
Two positions matter, and they are set by type. Non-energy-based Devices carries 36% of 2025 revenue (USD 8.5 billion) and is still the largest line in 2034 at 37%, hard to take from an incumbent. Energy-based Devices, at 11.05%, is where the USD 23.6 billion base is redistributed. The two demand different capabilities.
Further Report Findings
| Segment | Led 2025 by | Share & value | Fastest-growing |
|---|---|---|---|
| Application | Skin Resurfacing & Tightening | 28% · USD 6.61 billion | Body Contouring and Cellulite Reduction 11.14% |
| End-user | Specialty Clinics | 58% · USD 13.69 billion | — |
| Procedure type | Non-invasive | 40% · USD 9.44 billion | — |
| Gender | Female | 78% · USD 18.41 billion | Male 12.15% |
- Regionally, the lead sits with North America: 38.01% of 2025 global revenue, USD 8.97 billion rising to USD 19.04 billion in 2034.
- Asia Pacific takes a rising share of global revenue over the forecast period, from 26.02% in 2025 to 31% in 2034, with revenue growing from USD 6.14 billion to USD 17.36 billion.
- Middle East and Africa stays the smallest contributor across the period: 5% of revenue in 2025 and 5% in 2034.
- By type, the largest line in 2025 was Non-energy-based Devices, at 36% of revenue and USD 8.5 billion.
- Energy-based Devices is projected to grow at 11.05% over the forecast period, the fastest of any type line.
- The United States is the largest single country market at USD 7.62 billion in 2025, 32.29% of global revenue.
Coverage runs to five axes, by type, and by application, end-user, procedure type and gender, with a revenue figure and a growth rate for every line in every year from 2020 to 2034, and bear, base and bull cases on the headline total at USD 48.16 billion and USD 63.84 billion by 2034. All five regions are broken out to country level, alongside the competitive landscape and the methodology behind each estimate. The study is delivered as a PDF, and a free sample can be requested.